Ozempic Data Story
Using stock market data from Yahoo Finance, accessed via API, Regionalist created a dataset to investigate the impact of Ozempic’s FDA approval. Novo Nordisk’s stock price was compared to the aggregate prices of medical device manufactuors and processed food corporations. The results were striking! Device sales plummet after the June 4th, 2021 approval of the treatment of obesity with semaglutides.
Methodology: Analysis conducted in R with ggplot2. Adjusted stock prices gathered from January 1, 2020 to December 31, 2023 from Yahoo Finance. Graphic completed in Adobe Illustrator. Surgery manufacturers included the average price of Johnson & Johnson, Medtronic, Olympus, Boston Scientific, Asensus Surgical, ConMed, Intuitive Surgical, Apollo Endosurgery and ReShape Lifesciences. Processed food corporations included the average price of PepsiCo, Nestlé, Kraft Heinz, General Mills, Mondelez, Kellogg, Conagra, Campbell Soup and J.M. Smucker.
Source: Yahoo Finance, Google Trends